ATRA therapy is associated with the unique side effect of retinoic acid syndrome.[8] This is associated with the development of dyspnea, fever, weight gain, peripheral edema and is treated with dexamethasone.[9] The etiology of retinoic acid syndrome has been attributed to capillary leak syndrome from cytokine release from the differentiating promyelocytes.[9]